Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "Post"

1357 News Found

Sanofi India posts Q3CY22 net profit at Rs. 130.9 Cr
News | November 04, 2022

Sanofi India posts Q3CY22 net profit at Rs. 130.9 Cr

The company has reported total income of Rs. 703.3 crores during the period ended September 30, 2022


Vimta Labs posts consolidated PAT of Rs. 13.21 crores in Q2FY23
News | October 28, 2022

Vimta Labs posts consolidated PAT of Rs. 13.21 crores in Q2FY23

The company has posted net profit of Rs. 13.21 crores for the period ended September 30, 2022


Dabur India posts consolidated Q2 FY2023 PAT at Rs. 490.06 Cr
News | October 27, 2022

Dabur India posts consolidated Q2 FY2023 PAT at Rs. 490.06 Cr

The company has reported total income of Rs. 3109.77 crores during the period ended September 30, 2022


Merck’s PREVYMIS effective for prevention of cytomegalovirus disease in adults post kidney transplantation
Clinical Trials | October 23, 2022

Merck’s PREVYMIS effective for prevention of cytomegalovirus disease in adults post kidney transplantation

Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint


MedScapeIndia launches a poster of 'Girl Child Anthem'
News | October 20, 2022

MedScapeIndia launches a poster of 'Girl Child Anthem'

The girl child anthem will portray a celebration of a girl child.


Marksans Pharma posts Q1FY23consolidated PAT at Rs. 59.71 Cr
News | August 16, 2022

Marksans Pharma posts Q1FY23consolidated PAT at Rs. 59.71 Cr

The company has reported total income of Rs. 450.26 crores during the period ended June 30, 2022.


Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr
News | August 14, 2022

Parmax Pharma posts Q1 FY 23 loss at Rs. 1.31 Cr

The company has reported total income of Rs. 1.56 crores during the period ended June 30, 2022


Nectar Lifesciences posts Q1 FY23 consolidated PAT at Rs. 3.89 Cr
News | August 14, 2022

Nectar Lifesciences posts Q1 FY23 consolidated PAT at Rs. 3.89 Cr

The company has reported total income of Rs. 403.38 crores during the period ended June 30, 2022.


SMS Pharmaceuticals posts Q1FY23 consolidated loss at Rs. 12.76 Cr
News | August 14, 2022

SMS Pharmaceuticals posts Q1FY23 consolidated loss at Rs. 12.76 Cr

The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022.


Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr
News | August 12, 2022

Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr

Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.